We evaluate services for consistency with standards of care and best practices, and we look into each brand’s reputation before sharing products and services on Healthline. In 2024, 13 states cover GLP-1 drugs for obesity treatment, according to KFF, a nonpartisan health policy research group. Novo Nordisk is the only company in the United States with FDA-approved products c...
